Age-related frequency of triple negative breast cancer in women
- PMID: 24953912
Age-related frequency of triple negative breast cancer in women
Abstract
Objective: To determine frequency of triple negative breast cancer (TNBC) in Pakistani women with respect to age.
Study design: Observational study.
Place and duration of study: Armed Forces Institute of Pathology (AFIP), Rawalpindi, from July 2005 to July 2010.
Methodology: Pathological records of all specimens of breast cancer were reviewed and data was obtained for estrogen receptor (ER), progesterone receptor (PR) and HER-2 neu receptor proteins. Specimens having complete record of all three proteins were included for analysis. TNBC was defined as those who were ER, PR and HER-2 neu negative. Overall frequency as well as frequency with respect to age was calculated. Descriptive and categorical variables were analyzed using SPSS version 17.
Results: Eight hundred and fifteen patients out of 4715 (17.28%) were found to be TNBC. Mean age of diagnosis of TNBC was found to be 46.26 ± 12.22 years of age while other breast cancers had a mean age 52.90 ± 9.78 years (p < 0.001). In the TNBC group, 537 patients (65.88%) were aged < 50 years while 278 patients (34.11%) were aged > 50 years while majority of patients with other breast cancers were elderly females (p < 0.001).
Conclusion: TNBC comprised 17.28% of the breast cancers in Pakistani women diagnosed at the studied centre. A higher frequency of TNBC was noted in significantly younger patients.
Similar articles
-
Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103. J Coll Physicians Surg Pak. 2009. PMID: 19208313
-
Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.Breast. 2014 Oct;23(5):591-6. doi: 10.1016/j.breast.2014.06.006. Epub 2014 Jul 7. Breast. 2014. PMID: 25012047
-
[Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009].Klin Onkol. 2012;25(3):188-98. Klin Onkol. 2012. PMID: 22724568 Czech.
-
[Triple-negative breast carcinoma--rewiev of current literature].Magy Onkol. 2010 Dec;54(4):325-35. doi: 10.1556/MOnkol.54.2010.4.6. Magy Onkol. 2010. PMID: 21163763 Review. Hungarian.
-
An overview of triple negative breast cancer for surgical oncologists.Surg Oncol. 2015 Sep;24(3):276-83. doi: 10.1016/j.suronc.2015.06.007. Epub 2015 Jun 12. Surg Oncol. 2015. PMID: 26092709 Review.
Cited by
-
Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age.Front Oncol. 2021 Feb 8;10:636549. doi: 10.3389/fonc.2020.636549. eCollection 2020. Front Oncol. 2021. PMID: 33628740 Free PMC article.
-
Role of SOX10 Immunohistochemical Expression in Diagnosing Triple Negative Breast Cancer and Its Correlation With Clinicopathological Features.Cureus. 2024 Apr 29;16(4):e59276. doi: 10.7759/cureus.59276. eCollection 2024 Apr. Cureus. 2024. PMID: 38813332 Free PMC article.
-
Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment.Breast Cancer (Dove Med Press). 2021 Jan 11;13:31-44. doi: 10.2147/BCTT.S287320. eCollection 2021. Breast Cancer (Dove Med Press). 2021. PMID: 33469357 Free PMC article.
-
Breast Cancer Mortality Trends and Predictions to 2030 and Its Attributable Risk Factors in East and South Asian Countries.Front Nutr. 2022 Mar 14;9:847920. doi: 10.3389/fnut.2022.847920. eCollection 2022. Front Nutr. 2022. PMID: 35360680 Free PMC article.
-
Metabolomics-Based Discovery of Molecular Signatures for Triple Negative Breast Cancer in Asian Female Population.Sci Rep. 2020 Jan 15;10(1):370. doi: 10.1038/s41598-019-57068-5. Sci Rep. 2020. PMID: 31941951 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous